Clinical Trial Update: Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

This completed Phase 1/2 study evaluated the safety and tolerability of combining epigenetic and immunomodulating drugs with standard chemotherapy in patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: GWT-TUD GmbH | Conditions: Pancreas Cancer, Pancreatic Adenocarcinoma | Phase 1, Phase 2 | Status: COMPLETED